Titlebook: Macromolecular Anticancer Therapeutics; L. Harivardhan Reddy,Patrick Couvreur Book 2010 Springer-Verlag New York 2010 cancer.cancer therap

显示全部楼层 · 发表于 2025-3-26 23:19:10

Immunoconjugate Anticancer Therapeuticse “dock-and-lock” (DNL) technology enables the facile assembly of multifunctional structures of defined composition, combining the targeting and the therapeutic moieties site specifically. Recent advances in the use of different classes of immunoconjugates are described.

显示全部楼层 · 发表于 2025-3-27 01:48:18

显示全部楼层 · 发表于 2025-3-27 06:50:50

显示全部楼层 · 发表于 2025-3-27 12:32:44

Monoclonal Antibody Therapy for Hematologic Malignanciesmphomas in the Western world, is rituximab combined with chemotherapy. Second-generation anti-CD20 monoclonal antibodies are currently being studied in phase II and III trials. Radioimmunotherapy with anti-CD20 antibodies has also been approved by the FDA for the second-line treatment of follicular

显示全部楼层 · 发表于 2025-3-27 14:00:28

显示全部楼层 · 发表于 2025-3-27 18:22:45

显示全部楼层 · 发表于 2025-3-28 00:57:34

显示全部楼层 · 发表于 2025-3-28 03:13:30

显示全部楼层 · 发表于 2025-3-28 08:32:28

显示全部楼层 · 发表于 2025-3-28 10:55:12

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-28 02:29
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved